UN AIDS. Global HIV & AIDS statistics — Fact sheet. 2022; Available from: https://www.unaids.org/en/resources/fact-sheet.

Mathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030 | PLOS Medicine [Internet]. 2006 [cited 2023 Jun 6]. Available from: https://journals.plos.org/plosmedicine/articleid=10.1371/journal.pmed.0030442&utmsource=example.com&utm_medium=link&utm_compaign=article.

Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, Johns N, et al. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. Drug Alcohol Depend. 2014;137:36–47.

Article  PubMed  Google Scholar 

Farrell M, Martin NK, Stockings E, Bórquez A, Cepeda JA, Degenhardt L, et al. Responding to global stimulant use: challenges and opportunities. Lancet. 2019;394(10209):1652–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carrico AW, Riley ED, Johnson MO, Charlebois ED, Neilands TB, Remien RH, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of antiretroviral therapy utilization. JAIDS J Acquir Immune Defic Syndr. 2011;56(2):146.

Article  PubMed  Google Scholar 

Mayer KH, Skeer MR, O’Cleirigh C, Goshe BM, Safren SA. Factors associated with amplified HIV transmission behavior among American men who have sex with men engaged in care: implications for clinical providers. Ann Behav Med. 2014;47(2):165–71.

Article  PubMed  Google Scholar 

Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, et al. Stimulant use and progression to AIDS or mortality after the initiation of highly active anti-retroviral therapy. J Acquir Immune Defic Syndr 1999. 2014;67(5):508–13.

Article  CAS  Google Scholar 

Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, et al. Crack cocaine, disease progression, and mortality in a multi-center cohort of HIV-1 positive women. AIDS Lond Engl. 2008;22(11):1355–63.

Article  CAS  Google Scholar 

Masters MC, Krueger KM, Williams JL, Morrison L, Cohn SE. Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Rev Clin Pharmacol. 2019;12(12):1129–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bloch M, John M, Smith D, Rasmussen T, Wright E. Managing HIV-associated inflammation and ageing in the era of modern ART. HIV Med. 2020;21(S3):2–16.

Article  PubMed  Google Scholar 

Martin EG, Ansari B, Hart-Malloy R, Smith DK, Delaney KP, Gift TL, et al. Racial and ethnic disparities in HIV diagnoses among heterosexually active persons in the United States nationally and by state, 2018. PLoS ONE. 2021;16(9):e0257583.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cha S. HIV Infection risk, prevention, and testing behaviors among men who have sex with men National HIV behavioral surveillance 23 U.S. cities, 2017 [Internet]. 2019 [cited 2023 Jun 7]. Available from: https://stacks.cdc.gov/view/cdc/106350.

•• Carrico AW, Hunt PW, Neilands TB, Dilworth SE, Martin JN, Deeks SG, et al. Stimulant use and viral suppression in the era of universal antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr [Internet]. 2019;80(1). Available from: https://journals.lww.com/jaids/Fulltext/2019/01010/Stimulant_Use_and_Viral_Suppression_in_the_Era_of.15.aspx. Accessed 6 Jun 2023. Discuss the role of stimulant use in viral suppression in the context of treatment as prevention and the implications of the gut-brain axis in HIV pathogenesis.

Frescura L, Godfrey-Faussett P, Feizzadeh AA, El-Sadr W, Syarif O, Ghys PD, et al. Achieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS ONE. 2022;17(8):e0272405.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carrico AW, Neilands TB, Dilworth SE, Evans JL, Gόmez W, Jain JP, et al. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine. J Int AIDS Soc. 2019;22(12):e25436.

Article  PubMed  PubMed Central  Google Scholar 

Sortino O, Phanuphak N, Schuetz A, Ortiz AM, Chomchey N, Belkaid Y, et al. Impact of acute HIV infection and early antiretroviral therapy on the human gut microbiome. Open Forum Infect Dis. 2020;7(12):ofz367.

Article  PubMed  Google Scholar 

Sereti I, Krebs SJ, Phanuphak N, Fletcher JL, Slike B, Pinyakorn S, et al. Persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection. Clin Infect Dis Off Publ Infect Dis Soc Am. 2017;64(2):124–31.

Article  CAS  Google Scholar 

Hunt PW. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep. 2012;9(2):139–47.

Article  PubMed  Google Scholar 

Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol. 2013;21(1):6–13.

Article  CAS  PubMed  Google Scholar 

Rezaei S, Ahmadi S, Rahmati J, Hosseinifard H, Dehnad A, Aryankhesal A, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019;9(4):404–12.

PubMed  Google Scholar 

Ding Y, Lin H, Chen X, Zhu B, Xu X, Xu X, et al. Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection. eBioMedicine. 2021;71:103548.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei J, Hou J, Su B, Jiang T, Guo C, Wang W, et al. The prevalence of Frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis. Front Neurol [Internet]. 2020 [cited 2023 Jun 17];11. Available from: https://www.frontiersin.org/articles/10.3389/fneur.2020.581346. Accessed 6 Jun 2023

Javanbakht M, Shoptaw S, Ragsdale A, Brookmeyer R, Bolan R, Gorbach PM. Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM. Drug Alcohol Depend. 2020;207:107770. 

Chahine A, Koru-Sengul T, Feaster DJ, Dilworth SE, Antoni MH, Klatt N, et al. Blue Monday: co-occurring stimulant use and HIV persistence predict dysregulated catecholamine synthesis. JAIDS J Acquir Immune Defic Syndr. 2021;86(3):353.

Article  CAS  PubMed  Google Scholar 

Illenberger JM, Harrod SB, Mactutus CF, McLaurin KA, Kallianpur A, Booze RM. HIV infection and neurocognitive disorders in the context of chronic drug abuse: evidence for divergent findings dependent upon prior drug history. J Neuroimmune Pharmacol. 2020;15(4):715–28.

Article  PubMed  PubMed Central  Google Scholar 

Carrico AW, Cherenack EM, Rubin LH, McIntosh R, Ghanooni D, Chavez JV, et al. Through the looking-glass: psychoneuroimmunology and the microbiome-gut-brain axis in the modern antiretroviral therapy era. Psychosom Med. 2022;84(8):984–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Persons AL, Bradaric BD, Dodiya HB, Ohene-Nyako M, Forsyth CB, Keshavarzian A, et al. Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats. PLoS ONE. 2018;13(1):e0190078.

Article  PubMed  PubMed Central  Google Scholar 

Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med. 2010;2(32):32ra36-32ra36.

Article  PubMed  PubMed Central  Google Scholar 

Carrico AW, Johnson MO, Morin SF, Remien RH, Riley ED, Hecht FM, et al. Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy. Brain Behav Immun. 2008;22(8):1257–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Makisumi T, Yoshida K, Watanabe T, Tan N, Murakami N, Morimoto A. Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism. Eur J Pharmacol. 1998;363(2):107–12.

Article  CAS  PubMed  Google Scholar 

Cook RR, Fulcher JA, Tobin NH, Li F, Lee DJ, Woodward C, et al. Alterations to the gastrointestinal microbiome associated with methamphetamine use among young men who have sex with men. Sci Rep. 2019;9(1):14840.

Article  PubMed  PubMed Central  Google Scholar 

Martinez SS, Stebliankin V, Hernandez J, Martin H, Tamargo J, Rodriguez JB, et al. Multiomic analysis reveals microbiome-related relationships between cocaine use and metabolites. AIDS. 2022;36(15):2089–99.

Article  CAS  PubMed  Google Scholar 

•• Hernandez J, Tamargo JA, Sales Martinez S, Martin HR, Campa A, Sékaly RP, et al. Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort. Manuzak J, editor. PLoS ONE. 2022;17(10):e0275675. Discuss the role of stimulant use in viral suppression in the context of treatment as prevention and the implications of the gut-brain axis in HIV pathogenesis.

Miller M, Lee JY, Fulcher JA, Roach ME, Dilworth SE, Chahine A, et al. Getting to the point: methamphetamine injection is associated with biomarkers relevant to HIV pathogenesis. Drug Alcohol Depend. 2020;213:108133.

Article  CAS  PubMed  Google Scholar 

Gostner JM, Becker K, Kurz K, Fuchs D. Disturbed amino acid metabolism in HIV: association with neuropsychiatric symptoms. Front Psychiatry [Internet]. 2015 [cited 2023 Apr 3];6. Available from: https://www.frontiersin.org/articles/10.3389/fpsyt.2015.00097

Lee J, Lee JY, Meade CS, Cohn M, Chahine A, Dilworth SE, et al. Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection. J Neurovirol. 2020;26(5):779–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JY, Glynn TR, Moskowitz JT, Fuchs D, Neilands TB, Dilworth SE, et al. Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine. J Neurovirol. 2021;27(1):178–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, et al. Reversal of the kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr 1999. 2014;65(4):456–62.

Article  CAS  Google Scholar 

Clark JM, Sanders S, Carter M, Honeyman D, Cleo G, Auld Y, et al. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J Med Libr Assoc JMLA. 2020;108(2):195–207.

PubMed  Google Scholar 

Veritas Health Innovation. Covidence systematic review software [Internet]. Veritas Health Innovation; 2022. Available from: https://www.covidence.org. Accessed 6 Jun 2023

Adams JW, Marshall BDL, Mohd Salleh NA, Barrios R, Nolan S, Milloy MJ. Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs. Drug Alcohol Depend. 2020;206:107670.

Article  CAS  PubMed